Beating Bowel Cancer is proud to be involved in the Association of Coloproctology of Great Britain and Ireland’s (ACPGBI) new IMPACT initiative.
IMPACT will bring together all those involved in caring for patients with advanced colorectal cancer – defined as patients who have locally advanced or metastatic disease (disease which has spread to another organ) at the time of diagnosis or who develop local recurrence or metastases after treatment.
Surgeons, oncologists, radiologists, pathologists, nurses, patients and charity representatives gathered at the Royal College of Surgeons in London recently to hear a range of presentations relating to the complex needs of this group of patients.
The agenda included two exceptional patient talks, one delivered by Steve Clark, who does so much to support Beating Bowel Cancer in so many ways.
Key themes addressed included:
The ACPGBI will now develop a work plan to address these issues, with the ultimate goal being a set of ACPGBI guidelines specific to the management of advanced bowel cancer.
Patient and public involvement (PPI) –fundamentally important when designing and running research studies as patients bring valuable contributions by providing judgements based on their own experience and
understanding of their condition. Patients may also have different thoughts and ideas about what is important in terms of measuring outcomes and will often be able to predict whether a research study is likely to succeed by assessing whether the proposed research will seem acceptable to other patients.
Any major research funder will now only consider awarding a grant to researchers who have involved patients in study design and planning.
Beating Bowel Cancer fully supports the aims of IMPACT and look forward to reporting back on progress in due course.